Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

BCH-070, a novel antiparasitic candidate against multidrug-resistant malaria

April 21, 2020

First COVID-19 patient treated under emergency use IND with Stemedica's itMSCs

April 21, 2020

Anixa and OntoChem collaborate to develop novel antiviral therapies against COVID-19

April 21, 2020

Sinovac initiates phase I study of its vaccine candidate against COVID-19

April 21, 2020

U.K. MHRA clears 4D Pharma to begin phase II study of MRx-4DP0004 in COVID-19

April 20, 2020

Novartis plans phase III study of hydroxychloroquine in hospitalized patients with COVID-19 disease

April 20, 2020

Initiation of phase III RUXCOVID trial of ruxolitinib for COVID-19-associated cytokine storm

April 20, 2020

Ribonucleoside analogue EIDD-1931 is potently active against coronaviruses

April 20, 2020

Phase II study of Ad5-nCoV vaccine in healthy adults

April 20, 2020

Engineering better bacterial backstabbers

April 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...